Hydroquinone - @ - Pigment Agents- (FDC- List )- (Jan 2008)
Drug Name:Hydroquinone - @ - Pigment Agents- (FDC- List )- (Jan 2008)
List Of Brands:
Indication Type Description:
Indication
Adverse Reaction
Contra-Indications
Dosages/ Overdosage Etc
Patient Information
Pregnancy and lactation
Indication:
U.S FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
71.Hydroquinone 2% 31-01-08
+Tretinonin 0.025% (w/v)
+ Momentasone 0.10% Gel
For the short term intermittent treatment of moderate
to severe melasma of the face in the presence of
measures for sun avoidance including use of sun screen
Hyperpigmented skin
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
1.Hydroquinone 2% 31-01-2008
+Tretinoin 0.025%w/w
+ Momentasone 0.10% gel
For short term intermittant treatment of moderate to severe melasma
of the face in the presence of measures for sun avoidance including
use of sun screen
2.Hydroquinone 2% 23-02-2009
+ Tretionin 0.05%
+ Hydrocortisone 1% cream
For the treatment of patients with skin hyperpigmentation
3.Hydroquinone 20mg 23-02-2009
+ Tretionin 0.25mg
+ flucinolone acetonide 0.1mg per gm cream
For the treatment of melasma of face in adults
4.Hydroquinone USP 2% w/w 31-01-2011
+ Tretionin USP 0.25mg w/w
+ Allantoin USP 1%w/w gel
For the treatment of hyper pigmentary disorders
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
1.Hydroquinone 20mg + 23-02-2009
Tretionoin 0.25mg +
Fluocinolone acetonide 0.1mg per gm cream
2. Hydroquinone USP 2% w/w + 31-01-2011
Tretinoin USP 0.025% w/w +
Allantoin USP 1% w/w gel
For the treatment of hyper pigmentary disorders
3.Hydroquinone 20mg 23-02-2009
+ Tretionin 0.25mg
+ flucinolone acetonide 0.1mg per gm cream
For the treatment of melasma of face in adults
4.Hydroquinone USP 2% w/w 31-01-2011
+ Tretionin USP 0.25mg w/w
+ Allantoin USP 1%w/w gel
For the treatment of hyper pigmentary disorders